Observational study of SARS-CoV-2 antibody immune response in a cohort of patients at a North Suburban Chicago, Illinois, in a physician’s practice
Abstract
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. The application of point of care serological testing can help determine past infection and assist healthcare workers assess patient risk.
Method: An observational study of 114 subjects in North Suburban Chicago, Illinois, was performed using the Clungene® lateral flow immunoassay (LFI). Patients’ PCR test results and clinical symptoms were used to compare the seroconversion rate of this patient population with the surrounding community.
Results: Excluding 1 aberrant result, there was 100% positive agreement (10) between PCR and antibody (IgG or IgM) test results. There were 7 patients who did not have a prior PCR test who were positive for IgG; 5 of the 7 had clinical symptoms consistent with possible exposure and 2 were asymptomatic. There was 1 person with a suspected exposure to an infected person who was IgM positive. Ninety-five asymptomatic patients were seronegative. The overall rate of 15.9% seroconversion (IgG or IgM) is consistent with other community-based testing results in the North Suburban Chicago, Illinois area.
Conclusion: Rapid screening tests to identify antibody positive patients recovered from coronavirus disease-2019 can be a useful tool for healthcare professionals to determine or confirm past infection.
Statement of novelty: Limited data is available on the use of point of care serological testing to assist healthcare professionals with the assessment of their patient population regarding past SARS-CoV-2 infectivity and seroconversion. The present study successfully investigated the use of a point of care antibody test in a physician’s office to determine which patients have developed antibodies, indicating an immune response to SARS-CoV-2, and to assist with decisions on whether patients should pursue normal social and workplace activities.
Formats available
You can view the full content in the following formats:
REFERENCES
CDC. 2020. Interim guidelines for COVID-19 antibody testing [online]. Available from https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html#anchor_1590280385631.
CLUNGENE. 2020. CLUNGENE COVID-19 IgG/IgM Rapid Test Kit EUA submission # EUA201121.
FDA. 2020. FAQs on testing for SARS-CoV-2 [online]. Available from https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-testing-sars-cov-2.
Illinois Department of Health. 2020. COVID-19 statistics [online]. Available from https://www.dph.illinois.gov/covid19/covid19-statistics.
Long Q.X., Liu B.Z., Deng H.J., Wu G.C., Deng K., Chen Y.K., Liao P., Qiu J.F., Lin Y., Cai X.F., Wang D.Q., Hu Y., Ren J.H., Tang N., Xu Y.Y., Yu L.H., Mo Z., Gong F., Zhang X.L., Tian W.G., Hu L., Zhang X.X., Xiang J.L., Du H.X., Liu H.W., Lang C.H., Luo X.H., Wu S.B., Cui X.P., Zhou Z., Zhu M.M., Wang J., Xue C.J., Li X.F., Wang L., Li Z.J., Wang K., Niu C.C., Yang Q.J., Tang X.J., Zhang Y., Liu X.M., Li J.J., Zhang D.C., Zhang F., Liu P., Yuan J., Li Q., Hu J.L., Chen J., and Huang A.L. 2020. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat. Med. 26(6): 845–848.
Quest Diagnostics. 2020. IgG antibody serology testing to indicate SARS-CoV-2 exposure [online]. Available from https://www.questdiagnostics.com/home/Covid-19/HCP/antibody/.
Ragnesola B., Jin D., Lamb C.C., Shaz B.H., Hillyer C.D., and Luchsinger L.L. 2020. COVID 19 antibody detection using lateral flow assay tests in a cohort of convalescent plasma donors. BMC Res. Notes, 13(1): 372.
Seidenberg, B. 2020. NorthShore moving to convert Glenbrook Hospital into temporary site for COVID-19 patients [online]. Available from https://evanstonroundtable.com/Content/COVID-19/RT-Articles/Article/NorthShore-Moving-to-Convert-Glenbrook-Hospital-Into-Temporary-Site-for-Covid-19-Patients/41/237/17760.
Van Elslande J., Houben E., Depypere M., Brackenier A., Desmet S., André E., Van Ranst M., Lagrou K., and Vermeersch P. 2020. Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients. Clin. Microbiol. Infect. 26(8): 1082–1087.
Vásárhelyi B., Kristóf K., Ostorházi E., Szabó D., Prohászka Z., and Merkely B. 2020. The diagnostic value of rapid anti IgM and IgG detecting tests in the identification of patients with SARS CoV-2 virus infection. Orv. Hetil. 161(20): 807–812.
Wajnberg, A., Mansour, M., Leven, E., Bouvier, N. M., Patel, G., Firpo, A., Mendu, R., Jhang, J., Arinsburg, S., Gitman, M., Houldsworth, J., Baine, I., Simon, V., Aberg, J., Krammer, F., Reich, D., and Cordon-Cardo, C. 2020. Humoral immune response and prolonged PCR positivity in a cohort of 1343 SARS-CoV 2 patients in the New York City region. medRxiv.
Information & Authors
Information
Published In
LymphoSign Journal
Volume 7 • Number 3 • September 2020
Pages: 104 - 108
History
Received: 3 July 2020
Accepted: 5 August 2020
Accepted manuscript online: 6 August 2020
Copyright
© 2020.
Authors
Metrics & Citations
Metrics
Other Metrics
Citations
Cite As
GeraldOsher, Christopher C.Lamb, YulianaIbarra, and DeborahErickson-Samson. 2020. Observational study of SARS-CoV-2 antibody immune response in a cohort of patients at a North Suburban Chicago, Illinois, in a physician’s practice. LymphoSign Journal.
7(3): 104-108. https://doi.org/10.14785/lymphosign-2020-0007
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
Cited by
1. Point-Of-Care clinical evaluation of the Clungene® SARS-CoV-2 virus IgG/IgM 15-minute rapid test cassette with the Cobas® Roche RT-PCR platform in patients with or without Covid-19
View Options
Get Access
Login options
Check if you access through your login credentials or your institution to get full access on this article.
